Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023

SELL
$129.72 - $159.85 $466,992 - $575,460
-3,600 Reduced 10.71%
30,017 $4.78 Million
Q3 2022

Nov 01, 2022

SELL
$126.59 - $161.18 $329,134 - $419,068
-2,600 Reduced 7.18%
33,617 $4.48 Million
Q2 2022

Aug 03, 2022

SELL
$141.59 - $168.66 $906,176 - $1.08 Million
-6,400 Reduced 15.02%
36,217 $5.65 Million
Q1 2022

May 10, 2022

SELL
$129.64 - $160.7 $246,315 - $305,330
-1,900 Reduced 4.27%
42,617 $6.63 Million
Q2 2021

Aug 05, 2021

SELL
$160.2 - $186.42 $528,660 - $615,186
-3,300 Reduced 6.9%
44,517 $6.67 Million
Q4 2020

Feb 09, 2021

BUY
$140.71 - $165.05 $6.73 Million - $7.89 Million
47,817 New
47,817 $7.89 Million
Q3 2020

Nov 04, 2020

SELL
$105.46 - $144.13 $5.04 Million - $6.89 Million
-47,817 Closed
0 $0
Q2 2020

Jul 23, 2020

SELL
$95.68 - $121.88 $57,408 - $73,128
-600 Reduced 1.24%
47,817 $5.28 Million
Q1 2020

May 12, 2020

SELL
$87.74 - $152.74 $271,994 - $473,494
-3,100 Reduced 6.02%
48,417 $4.83 Million
Q4 2019

Feb 12, 2020

BUY
$117.65 - $153.73 $211,770 - $276,714
1,800 Added 3.62%
51,517 $7.69 Million
Q3 2019

Nov 12, 2019

BUY
$125.18 - $143.24 $2.51 Million - $2.88 Million
20,073 Added 67.71%
49,717 $6.37 Million
Q2 2019

Jul 25, 2019

SELL
$125.55 - $144.48 $414,315 - $476,783
-3,300 Reduced 10.02%
29,644 $4.23 Million
Q1 2019

May 06, 2019

BUY
$121.81 - $142.95 $36,543 - $42,885
300 Added 0.92%
32,944 $4.71 Million
Q4 2018

Feb 12, 2019

BUY
$115.94 - $166.74 $2.7 Million - $3.89 Million
23,317 Added 249.99%
32,644 $3.54 Million
Q4 2017

Feb 02, 2018

SELL
$131.06 - $150.39 $52,424 - $60,155
-400 Reduced 4.11%
9,327 $1.05 Million
Q3 2017

Nov 01, 2017

BUY
$142.62 - $155.6 $1.39 Million - $1.51 Million
9,727
9,727 $1.42 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Mn Services Vermogensbeheer B.V. Portfolio

Follow Mn Services Vermogensbeheer B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.